News

If Brinavess successfully completes the Phase I trial, which will be conducted in healthy volunteers, Eddingpharm intends to start a pivotal Phase III study by year end. Cardiome

The drug is approved for adults who require additional lowering of low-density lipoprotein (LDL) cholesterol. Praluent is the FDA-approved treatment in a new class of drugs known as

Technivie is an all-oral, interferon-free, direct-acting antiviral treatment consisting of the fixed-dose combination of paritaprevir/ritonavir (150/100mg) co-formulated with ombitasvir (25mg) dosed once daily and taken with a meal,

Following the positive opinion, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunization programs once approved by national

Naramin relieves the symptoms of hayfever/allergy including sneezing, runny nose, itchy watery eyes and itchy throat. It’s easy to carry for people on-the-go when you fly, camp, fish

This 505(b)(2) NDA requests FDA approval of Eagle’s RTU bivalirudin product for the treatment of patients: undergoing percutaneous coronary intervention (PCI) with use of glycoprotein IIb/IIIa inhibitor, undergoing

The proprietary combination of salts and amino acids has been engineered to create small and dense particles possessing properties that have the potential to enable or improve new

Based on the results presented at the biannual meeting July 10th in Heidelberg, Germany, Merck Serono decided to extend the funding of the first two international research groups

The EMA will initiate review of the MAA under accelerated assessment timelines. "Given the diversity of patient populations affected by chronic hepatitis C, including the estimated 15 million